Establishment of a liver cancer interventional therapy database and its application in real-world research of liver cancer embolization intervention

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037595

Enrollment

Unknown

Registered

2020-08-29

Start date

2020-11-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with liver cancer who are diagnosed by clinicians and require interventional embolization

Exclusion criteria

Exclusion criteria: Patients with contraindications to interventional embolization

Design outcomes

Primary

Measure	Time frame
Objective response rate;	—

Secondary

Measure	Time frame
One-year survival rate;Three-years survival rate;	—

Countries

China

Contacts

Public ContactWenge Xing

Tianjin Medical University Cancer Hospital

xingwenge@tjmuch.com+86 18622221216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026